# Argus® II Retinal Prosthesis System Post-Market Surveillance Study

> **NCT01490827** · — · TERMINATED · sponsor: **Second Sight Medical Products** · enrollment: 52 (actual)

## Conditions studied

- Outer Retinal Degeneration
- Retinitis Pigmentosa

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01490827
- **Lead sponsor:** Second Sight Medical Products
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2011-11
- **Primary completion:** 2020-03-31
- **Final completion:** 2020-03-31
- **Target enrollment:** 52 (ACTUAL)
- **Why stopped:** Sponsor discontinued the Argus II product
- **Last updated:** 2020-05-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01490827

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01490827, "Argus® II Retinal Prosthesis System Post-Market Surveillance Study". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01490827. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*